|
Market Closed -
Sao Paulo
01:12:45 22/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 79.00 BRL | +0.56% |
|
+2.60% | +19.77% |
| 21/10 | Barclays Adjusts Price Target on Amgen to $400 From $380 | MT |
| 21/10 | Positive Results for an AstraZeneca and Amgen Product |  |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 24TCr | |||||
| 1,13300Cr | |||||
| 62TCr | |||||
| 50TCr | |||||
| 38TCr | |||||
| 37TCr |
Select your edition
All financial news and data tailored to specific country editions
